Medico Remedies Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 40.03 | 31.09 | 41.91 |
| Operating Expense | 36.94 | 27.99 | 36.68 |
| Net Profit | 1.55 | 1.58 | 3.10 |
| Net Profit Margin | 3.87 | 5.08 | 7.40 |
| Earning Per Share | 0.19 | 0.19 | 0.37 |
| EBIDTA | 3.11 | 3.04 | 5.28 |
| Effective Tax Rate | 19.42 | 17.10 | 22.75 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 40.03 |
| Operating Expense | 36.94 |
| Net Profit | 1.55 |
| Net Profit Margin | 3.87 |
| Earning Per Share | 0.19 |
| EBIDTA | 3.11 |
| Effective Tax Rate | 19.42 |
Invest in Medico Remedies Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 144.92 | 140.44 | 121.02 |
| Operating Expenses Annual | 132.01 | 130.82 | 113.69 |
| Operating Profit Annual | 15.04 | 13.57 | 9.36 |
| Interest Annual | 0.82 | 0.75 | 0.66 |
| Depreciation | 2.46 | 2.31 | 2.08 |
| Net Profit Annual | 8.29 | 7.24 | 4.81 |
| Tax Annual | 3.04 | 2.86 | 1.67 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 144.92 |
| Operating Expenses Annual | 132.01 |
| Operating Profit Annual | 15.04 |
| Interest Annual | 0.82 |
| Depreciation | 2.46 |
| Net Profit Annual | 8.29 |
| Tax Annual | 3.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.91 | 1.17 | 2.83 |
| Cash Flow from Operations | 2.68 | 8.17 | 5.86 |
| Cash Flow from Investing | -2.92 | -6.60 | -1.76 |
| Cash Flow from Financing | -0.49 | -1.82 | -5.77 |
| Cash Flow at the End | 0.18 | 0.91 | 1.17 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.91 |
| Cash Flow from Operations | 2.68 |
| Cash Flow from Investing | -2.92 |
| Cash Flow from Financing | -0.49 |
| Cash Flow at the End | 0.18 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 10.37 | 9.66 | 7.73 |
| PBIT Margin (%) | 8.38 | 7.73 | 5.90 |
| PBT Margin (%) | -1.85 | -2.57 | -3.04 |
| Net PROFIT Margin (%) | 5.72 | 5.16 | 3.97 |
| Return On Networth / Equity (%) | 17.23 | 18 | 13.93 |
| Return On Networth /Employed (%) | 21.24 | 21.01 | 14.74 |
| Return On Assets (%) | 14.47 | 14.02 | 9.94 |
| Total Debt / Equity (X) | 0.19 | 0.28 | 0.40 |
| Asset Turnover Ratio (%) | 2.53 | 2.72 | 2.50 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 10.37 |
| PBIT Margin (%) | 8.38 |
| PBT Margin (%) | -1.85 |
| Net PROFIT Margin (%) | 5.72 |
| Return On Networth / Equity (%) | 17.23 |
| Return On Networth /Employed (%) | 21.24 |
| Return On Assets (%) | 14.47 |
| Total Debt / Equity (X) | 0.19 |
| Asset Turnover Ratio (%) | 2.53 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 21.49 | 21.90 | 18.03 |
| Total Current Assets Annual | 73.76 | 64.54 | 57.57 |
| Non Current Assets Annual | 22.43 | 22.91 | 19.83 |
| Total Shareholders Funds Annual | 52.37 | 43.84 | 36.57 |
| Total Assets Annual | 96.20 | 87.45 | 77.40 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 21.49 |
| Total Current Assets Annual | 73.76 |
| Non Current Assets Annual | 22.43 |
| Total Shareholders Funds Annual | 52.37 |
| Total Assets Annual | 96.20 |
No Data Availabe
